Quantitative Evaluation of Clinical Outcomes of Levonorgestrel-Releasing IUCD (LNG-IUS) in Heavy Menstrual Bleeding: a Comparative Study
Article Sidebar
Main Article Content
Abstract
One of the widespread diseases affecting the reproductive system in women is heavy menstrual bleeding, causing many complications such as iron deficiency anemia and fatigue, and lowering the quality of life of women significantly. In this paper, the efficacy of hormonal intrauterine contraception is evaluated in order to meet the demand for efficient treatment methods that have long-lasting effects without surgeries. The purpose of the current work is to perform a quantitative analysis of the clinical effectiveness in terms of decrease in menstrual blood loss, improvement in blood indicators, pain relief, menstruation disappearance, and patients' satisfaction. It is necessary to analyze the results of randomized clinical trials, prospective cohorts, and systematic reviews on the subject matter. The obtained data suggest the presence of a significant decrease in menstrual blood loss, improvement in hemoglobin level, and pain symptoms. Many patients stopped having menses while using the new method. It proved to be more efficient, satisfactory, and easier to continue compared to conventional therapies. Thus, this article offers a unique analysis combining quantitative measures and comparative evaluation of the effect of the therapy on patients' health.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
References
National Institute for Health and Care Excellence. (2018). Heavy menstrual bleeding: Assessment and management (NG88). https://www.nice.org.uk/guidance/ng88
Munro, M. G., Critchley, H. O. D., Broder, M. S., & Fraser, I. S. (2011). FIGO classification system (PALM–COEIN) for causes of abnormal uterine bleeding in non-gravid women of reproductive age. International Journal of Gynaecology & Obstetrics, 113(1), 3–13. https://doi.org/10.1016/j.ijgo.2010.11.011
Fraser, I. S., Mansour, D., Breymann, C., Hoffman, C., &
Mezzacasa, A. (2007). Prevalence of heavy menstrual bleeding and experiences of affected women. Human Reproduction Update, 13(2), 121–134. https://doi.org/10.1093/humupd/dml042
Maybin, J. A., & Critchley, H. O. D. (2015). Medical management of heavy menstrual bleeding. Women’s Health, 11(1), 27–34. https://doi.org/10.2217/whe.14.79
Shankar, M., Lee, C. A., Sabin, C. A., Economides, D. L.,
Kadir, R. A., & Kadir, R. A. (2004). Von Willebrand disease in women with menorrhagia: A systematic review. British Journal of Haematology, 124(4), 483–491. https://doi.org/10.1046/j.1365-2141.2003.04859.x
American College of Obstetricians and Gynaecologists. (2021). Management of abnormal uterine bleeding in reproductive-aged women. https://www.acog.org/clinical
Kaunitz, A. M., Inki, P., Kubba, A., & others. (2010). Levonorgestrel-releasing intrauterine system and endometrial suppression. Obstetrics & Gynaecology, 116(3), 625–632. https://doi.org/10.1097/AOG.0b013e3181d8b3d1
Bahamondes, L., Fernandes, A., & Bahamondes, M. V. (2015). Long-term use of the levonorgestrel-releasing intrauterine system. Contraception, 91(3), 170–176. https://doi.org/10.1016/j.contraception.2014.07.014
Endrikat, J., Shapiro, H., Lukkari-Lax, E., & others. (2012). Clinical performance of the levonorgestrel-releasing intrauterine system in heavy menstrual bleeding. European Journal of Obstetrics & Gynaecology and Reproductive Biology, 164(1), 83–88. https://doi.org/10.1016/j.ejogrb.2012.03.019
Cochrane Collaboration. (2020). Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding. https://www.cochranelibrary.com
Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., & Roberts, T. E. (2013). Levonorgestrel intrauterine system versus usual medical treatment for heavy menstrual bleeding. New England Journal of Medicine, 368(2), 128–137. https://doi.org/10.1056/NEJMoa1204724
World Health Organization. (2018). WHO recommendations on reproductive health. https://www.who.int
Hurskainen, R., Teperi, J., Rissanen, P., Aalto, A. M., Grenman, S., Kivelä, A., & Paavonen, J. (2001). Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia. JAMA, 286(2), 144–151. https://doi.org/10.1001/jama.286.2.144
Lethaby, A., Hussain, M., Rishworth, J. R., & Rees, M. C. (2015). Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, (4), CD002126. https://doi.org/10.1002/14651858.CD002126.pub3
Irvine, G. A., Campbell-Brown, M. B., Lumsden, M. A., Heikkilä, A., Walker, J. J., & Cameron, I. T. (1998). Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. BMJ, 316(7138), 1123–1127. https://doi.org/10.1136/bmj.316.7138.1123
Reid, P. C., & Virtanen-Kari, S. (2005). Randomised comparative trial of the levonorgestrel intrauterine system and oral medroxyprogesterone acetate in women with menorrhagia. BJOG, 112(8), 1121–1126. https://doi.org/10.1111/j.1471-0528.2005.00671.x
Matteson, K. A., Rahn, D. D., Wheeler, T. L., Casiano, E.,
Siddiqui, N. Y., Harvie, H. S., & Balk, E. M. (2013). Nonsurgical management of heavy menstrual bleeding: A systematic review. Obstetrics & Gynaecology, 121(3), 632–643. https://doi.org/10.1097/AOG.0b013e3182839e0d
Marjoribanks, J., Lethaby, A., Farquhar, C., & Sowter, M. (2016). Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, (1), CD003855. https://doi.org/10.1002/14651858.CD003855.pub5
Middleton, L. J., Champaneria, R., Daniels, J. P., Hirschelmann, A., Bhattacharya, S., Cooper, K. G., & Gupta, J. K. (2011). Hysterectomy, endometrial destruction and levonorgestrel-releasing intrauterine system for heavy menstrual bleeding. Health Technology Assessment, 15(19), 1–252. https://doi.org/10.3310/hta15190
Milsom, I., Andersson, K., Jonasson, K., Lindstedt, G., & Rybo, G. (1991). The influence of the levonorgestrel-releasing intrauterine system on menstrual blood loss and iron status. Contraception, 44(5), 485–496. https://doi.org/10.1016/0010-7824(91)90085-K
Xiao, B., Wu, S. C., Chong, J., Zeng, T., Han, L. H.,
Luukkainen, T., & Allonen, H. (2003). Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertility and Sterility, 79(4), 963–969. https://doi.org/10.1016/S0015-0282(02)04948-4
Kaunitz, A. M. (2007). Intrauterine devices and intrauterine systems: Medical and noncontraceptive benefits. American Journal of Obstetrics and Gynaecology, 197(2), 134–138. https://doi.org/10.1016/j.ajog.2007.05.031
Stewart, A., Cummins, C., Gold, L., Jordan, R., & Phillips, W. (2001). The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: A systematic review. BJOG, 108(1), 74–86. https://doi.org/10.1111/j.1471-0528.2001.00017.x
Higham, J. M., O’Brien, P. M. S., & Shaw, R. W. (1990). Assessment of menstrual blood loss using a pictorial chart. BJOG, 97(8), 734–739. https://doi.org/10.1111/j.1471-0528.1990.tb16249.x
Fraser, I. S., McCarron, G., & Markham, R. (1984). A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics and Gynaecology, 149(7), 788–793. https://doi.org/10.1016/0002-9378(84)90679-9
Warner, P., Critchley, H. O. D., Lumsden, M. A., Campbell-Brown, M., Douglas, A., & Murray, G. D. (2004). Menorrhagia II: Is the 80 mL blood loss criterion useful in management? American Journal of Obstetrics and Gynaecology, 190(5), 1224–1229. https://doi.org/10.1016/j.ajog.2003.11.043
Janssen, C. A., Scholten, P. C., & Heintz, A. P. (1995). A simple visual assessment technique to estimate menstrual blood loss. Obstetrics & Gynaecology, 85(6), 977–982. https://doi.org/10.1016/0029-7844(95)00068-V
Hallberg, L., Högdahl, A. M., Nilsson, L., & Rybo, G. (1966). Menstrual blood loss—a population study. Acta Obstetricia et Gynaecological Scandinavica, 45(3), 320–351. https://doi.org/10.3109/00016346609158428
Coulter, A., Kelland, J., Peto, V., & Rees, M. C. (1994). Treating menorrhagia in primary care: An overview of drug trials. BMJ, 308(6940), 1343–1348. https://doi.org/10.1136/bmj.308.6940.1343
Duckitt, K., & Collins, S. (2008). Menorrhagia. Clinical Evidence, 2008, 0815.
Kriplani, A., Singh, B. M., Lal, S., Agarwal, N., & Kulshrestha, V. (2006). Efficacy, acceptability, and side effects of levonorgestrel intrauterine system in idiopathic menorrhagia. Journal of Obstetrics and Gynaecology Research, 32(4), 429–435. https://doi.org/10.1111/j.1447-0756.2006.00420.x
Nelson, A. L., & Massoudi, N. (2016). New developments in intrauterine device use: Focus on the US. Open Access Journal of Contraception, 7, 127–141. https://doi.org/10.2147/OAJC.S85564